US 10005771
Bicyclic derivatives having β2 adrenergic agonist and M3 muscarinic antagonist activities
granted A61PA61P1/00A61P11/00
Quick answer
US patent 10005771 (Bicyclic derivatives having β2 adrenergic agonist and M3 muscarinic antagonist activities) held by Almirall, S.A. expires Mon Jun 21 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Almirall, S.A.
- Grant date
- Tue Jun 26 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 21 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 26
- CPC classes
- A61P, A61P1/00, A61P11/00, A61P11/06, A61P13/02